Would you recommend empiric coverage for vancomycin-resistance enterococcus in an unstable patient with sepsis, multiple comorbidities, and a recent ICU stay in a high VRE prevalence unit, despite recent cultures without growth of VRE?  

I would go back to the assessment of community onset vs hospital onset as to when the sepsis is "setting in." If patient is coming from the community, hasn't had antibiotics in the last 90 days, hospitalized in the last 90 days, has no positive microbiology for VRE in the last year, then no, I would...